Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
172M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
89.1M
-
Shares change
-
+3.65M
-
Total reported value, excl. options
-
$3.26B
-
Value change
-
+$138M
-
Number of buys
-
71
-
Number of sells
-
-44
-
Price
-
$36.59
Significant Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) as of Q2 2021
146 filings reported holding RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2021.
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.1M shares
of 172M outstanding shares and own 51.91% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (27.9M shares), FMR LLC (10.4M shares), BlackRock Inc. (4.54M shares), EcoR1 Capital, LLC (4.49M shares), VANGUARD GROUP INC (4.29M shares), Casdin Capital, LLC (3.38M shares), BVF INC/IL (2.94M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2.85M shares), Bellevue Group AG (2.64M shares), and STATE STREET CORP (2.22M shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.